Compounds > 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Melanoma

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Melanoma in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (53.85)	29.6817
2010's	6 (46.15)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chakraborty, S; Pillai, MR; Sarma, HD; Vimalnath, KV	1
Aboagye, EO; Alam, IS; Gallo, J; Gu, YJ; Jin, J; Long, NJ; Wong, WT	1
Gershman, BM; Guo, H; Miao, Y; Shenoy, N; Sklar, LA; Yang, J	1
Bapst, JP; Calame, M; Eberle, AN; Tanner, H	1
Cantorias, MV; Carmack, TL; Cutler, CS; Figueroa, SD; Hoffman, TJ; Lever, JR; Quinn, TP; Watkinson, LD	1
Gallazzi, F; Guo, H; Miao, Y; Yang, J	1
Bergman, M; Huttunen, M; Luoto, P; Peräkylä, H; Roivainen, A; Simpura, I; Ujula, T; Wilson, I	1
Dearling, JL; Dunning, P; Fahey, F; Huston, JS; Meares, CF; Packard, AB; Smith, SV; Snay, E; Treves, ST; Voss, SD	1
Barfield, RC; Butch, ER; Dearling, JL; Navid, F; Packard, AB; Shulkin, BL; Snyder, SE; Vavere, AL	1
Calame-Christe, M; Eberle, AN; Froidevaux, S; Tanner, H	1
Miao, Y; Quinn, TP; Shelton, T	1
Figueroa, SD; Fisher, DR; Hoffman, TJ; Miao, Y; Moore, HA; Quinn, TP; Testa, RF	1
Chen, J; Cheng, Z; Jurisson, SS; Miao, Y; Owen, NK; Quinn, TP	1

Other Studies

13 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Melanoma

Article	Year
Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer. Nuclear medicine and biology, 2013, Volume: 40, Issue:7 Topics: Animals; Dimerization; Drug Stability; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Lutetium; Melanoma; Mice; Octanols; Peptides, Cyclic; Radiation Dosage; Radioactive Tracers; Radiochemistry; Radioisotopes; Water	2013
PET imaging with multimodal upconversion nanoparticles. Dalton transactions (Cambridge, England : 2003), 2014, Apr-14, Volume: 43, Issue:14 Topics: Animals; Cell Line, Tumor; Contrast Media; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Melanoma; Mice; Microscopy, Electron, Transmission; Nanoparticles; Oligopeptides; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals	2014
Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide. Nuclear medicine and biology, 2009, Volume: 36, Issue:3 Topics: alpha-MSH; Amino Acid Sequence; Animals; Binding, Competitive; Cell Line, Tumor; Feasibility Studies; Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Lactams; Melanoma; Mice; Neoplasm Metastasis; Neoplasm Staging; Peptides, Cyclic; Reproducibility of Results; Staining and Labeling; Time Factors; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2009
Glycosylated DOTA-alpha-melanocyte-stimulating hormone analogues for melanoma targeting: influence of the site of glycosylation on in vivo biodistribution. Bioconjugate chemistry, 2009, May-20, Volume: 20, Issue:5 Topics: alpha-MSH; Animals; Binding Sites; Biological Transport; Carbohydrates; Cell Line, Tumor; Female; Glycopeptides; Glycosylation; Heterocyclic Compounds, 1-Ring; Humans; Melanoma; Mice; Peptide Fragments; Receptor, Melanocortin, Type 1	2009
Development of high-specific-activity (68)Ga-labeled DOTA-rhenium-cyclized alpha-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors. Nuclear medicine and biology, 2009, Volume: 36, Issue:5 Topics: Acetic Acid; Animals; Cell Line, Tumor; Chromatography, High Pressure Liquid; Cyclization; Female; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Melanocyte-Stimulating Hormones; Melanoma; Mice; Mice, Inbred C57BL; Microwaves; Positron-Emission Tomography; Receptor, Melanocortin, Type 1; Rhenium; Staining and Labeling; Substrate Specificity; Tissue Distribution	2009
Reduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptake. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:3 Topics: alpha-MSH; Amino Acid Sequence; Animals; Biological Transport; Cell Line, Tumor; Chelating Agents; Cyclization; Female; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Lactams; Melanoma; Mice; Receptor, Melanocortin, Type 1; Structure-Activity Relationship; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2010
Matrix metalloproteinase 9 targeting peptides: syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model. Bioconjugate chemistry, 2010, Sep-15, Volume: 21, Issue:9 Topics: Animals; Cell Line, Tumor; Cystine; Disease Models, Animal; Drug Evaluation; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Kinetics; Matrix Metalloproteinase 9; Melanoma; Peptides; Positron-Emission Tomography; Rats; Tissue Distribution; Transplantation, Heterologous; Tumor Protein, Translationally-Controlled 1	2010
Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody. Nuclear medicine and biology, 2011, Volume: 38, Issue:1 Topics: Aniline Compounds; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Copper Radioisotopes; Cross-Linking Reagents; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Melanoma; Mice; Positron-Emission Tomography	2011
64Cu-p-NH2-Bn-DOTA-hu14.18K322A, a PET radiotracer targeting neuroblastoma and melanoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:11 Topics: Animals; Antibodies; Cell Line, Tumor; Copper Radioisotopes; Female; Gangliosides; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; Melanoma; Mice; Neuroblastoma; Positron-Emission Tomography; Radioactive Tracers; Recombinant Fusion Proteins	2012
Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:5 Topics: alpha-MSH; Animals; Cell Line, Tumor; Drug Delivery Systems; Female; Heterocyclic Compounds, 1-Ring; Kidney; Melanoma; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Structure-Activity Relationship; Tissue Distribution	2005
Therapeutic efficacy of a 177Lu-labeled DOTA conjugated alpha-melanocyte-stimulating hormone peptide in a murine melanoma-bearing mouse model. Cancer biotherapy & radiopharmaceuticals, 2007, Volume: 22, Issue:3 Topics: alpha-MSH; Animals; Arginine; Chelating Agents; Disease Models, Animal; Heterocyclic Compounds, 1-Ring; Kidney; Lutetium; Melanoma; Mice; Radiography; Radioisotopes; Survival Analysis	2007
203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:5 Topics: alpha-MSH; Amino Acid Sequence; Animals; Cell Line, Tumor; Heterocyclic Compounds, 1-Ring; Lead Radioisotopes; Melanoma; Mice; Organotechnetium Compounds; Peptide Fragments; Phantoms, Imaging; Receptor, Melanocortin, Type 1; Tomography, Emission-Computed, Single-Photon	2008
Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues. Journal of medicinal chemistry, 2002, Jul-04, Volume: 45, Issue:14 Topics: alpha-MSH; Animals; Binding, Competitive; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Isotope Labeling; Melanoma; Mice; Mice, Inbred C57BL; Organometallic Compounds; Peptides, Cyclic; Radiopharmaceuticals; Rhenium; Tissue Distribution; Tumor Cells, Cultured	2002